Campbell Wealth Management’s Biogen BIIB Stock Holding History

Campbell Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13	Closed	-$3K	–	95
2020 Q2	$3K	Buy	+13	New	+$3.91K	﹤0.01%	318

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Campbell Wealth Management's BIIB Position: Q3 2020 in Review

Campbell Wealth Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 13 shares — an estimated $3K sold.

Campbell Wealth Management first reported a position in BIIB in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Campbell Wealth Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Campbell Wealth Management sold 13 Biogen shares in Q3 2020, an estimated $3K.
Campbell Wealth Management first reported a position in Biogen in Q2 2020 and held it in 1 quarter.
Campbell Wealth Management's Biogen position peaked at $3K in Q2 2020.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Campbell Wealth Management's 13F filing for Q3 2020, filed 2 Nov 2020.